• レポートコード:GIR201112597 • 出版社/出版日:GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、106ページ • 納品方法:Eメール • 産業分類:医薬品・医療 |
Single User | ¥522,000 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥783,000 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本書では、インスリンの世界市場を調査対象にし、インスリンの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(動物インスリン、通常ヒトインスリン、インスリンアナログ)、用途別分析(短時間演技、中演、長時間演技、プレミックスXXX)、市場予測(2021年~2025年)、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報:Novo Nordisk、Tonghua Dongbao、Eli Lilly、Jiangsu Wanbang、Sanofi-Aventis、United Laboratory、Ganlee ・メーカー別販売量、売上、市場シェア ・インスリンの地域別市場分析 ・インスリンの北米市場規模2015-2020:アメリカ、カナダ、メキシコ ・インスリンのヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど ・インスリンのアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど ・インスリンの南米市場規模2015-2020:ブラジル、アルゼンチンなど ・インスリンの中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど ・インスリンの種類別市場規模2015-2020:動物インスリン、通常ヒトインスリン、インスリンアナログ ・インスリンの用途別市場規模2015-2020:短時間演技、中演、長時間演技、プレミックスXXX ・インスリンの世界市場予測2021-2025:地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The Insulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Insulin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Insulin market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Insulin market has been segmented into
Animal Insulin
Regular Human Insulin
Insulin Analogue
By Application, Insulin has been segmented into:
Short acting
Intermediate acting
Long acting
Pre-mix Insulin
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Insulin market presented in the report. This section sheds light on the sales growth of different regional and country-level Insulin markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Insulin market.
The report offers in-depth assessment of the growth and other aspects of the Insulin market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Insulin Market Share Analysis
Insulin competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Insulin sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Insulin sales, revenue and market share for each player covered in this report.
The major players covered in Insulin are:
Novo Nordisk
Tonghua Dongbao
Eli Lilly
Jiangsu Wanbang
Sanofi-Aventis
United Laboratory
Ganlee
Among other players domestic and global, Insulin market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Insulin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Insulin, with price, sales, revenue and global market share of Insulin in 2018 and 2019.
Chapter 3, the Insulin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Insulin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Insulin market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Insulin sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Insulin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Insulin Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Animal Insulin
1.2.3 Regular Human Insulin
1.2.4 Insulin Analogue
1.3 Market Analysis by Application
1.3.1 Overview: Global Insulin Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Short acting
1.3.3 Intermediate acting
1.3.4 Long acting
1.3.5 Pre-mix Insulin
1.4 Overview of Global Insulin Market
1.4.1 Global Insulin Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business
2.1.3 Novo Nordisk SWOT Analysis
2.1.4 Novo Nordisk Product and Services
2.1.5 Novo Nordisk Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Tonghua Dongbao
2.2.1 Tonghua Dongbao Details
2.2.2 Tonghua Dongbao Major Business
2.2.3 Tonghua Dongbao SWOT Analysis
2.2.4 Tonghua Dongbao Product and Services
2.2.5 Tonghua Dongbao Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Eli Lilly
2.3.1 Eli Lilly Details
2.3.2 Eli Lilly Major Business
2.3.3 Eli Lilly SWOT Analysis
2.3.4 Eli Lilly Product and Services
2.3.5 Eli Lilly Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Jiangsu Wanbang
2.4.1 Jiangsu Wanbang Details
2.4.2 Jiangsu Wanbang Major Business
2.4.3 Jiangsu Wanbang SWOT Analysis
2.4.4 Jiangsu Wanbang Product and Services
2.4.5 Jiangsu Wanbang Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi-Aventis
2.5.1 Sanofi-Aventis Details
2.5.2 Sanofi-Aventis Major Business
2.5.3 Sanofi-Aventis SWOT Analysis
2.5.4 Sanofi-Aventis Product and Services
2.5.5 Sanofi-Aventis Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 United Laboratory
2.6.1 United Laboratory Details
2.6.2 United Laboratory Major Business
2.6.3 United Laboratory Product and Services
2.6.4 United Laboratory Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Ganlee
2.7.1 Ganlee Details
2.7.2 Ganlee Major Business
2.7.3 Ganlee Product and Services
2.7.4 Ganlee Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Insulin Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Insulin Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Insulin Manufacturer Market Share in 2019
3.3.2 Top 6 Insulin Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Insulin Sales, Revenue and Market Share by Regions
4.1.1 Global Insulin Sales and Market Share by Regions (2015-2020)
4.1.2 Global Insulin Revenue and Market Share by Regions (2015-2020)
4.2 North America Insulin Sales and Growth Rate (2015-2020)
4.3 Europe Insulin Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Insulin Sales and Growth Rate (2015-2020)
4.5 South America Insulin Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Insulin Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Insulin Sales, Revenue and Market Share by Country
5.1.1 North America Insulin Sales and Market Share by Country (2015-2020)
5.1.2 North America Insulin Revenue and Market Share by Country (2015-2020)
5.2 United States Insulin Sales and Growth Rate (2015-2020)
5.3 Canada Insulin Sales and Growth Rate (2015-2020)
5.4 Mexico Insulin Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Insulin Sales, Revenue and Market Share by Country
6.1.1 Europe Insulin Sales and Market Share by Country (2015-2020)
6.1.2 Europe Insulin Revenue and Market Share by Country (2015-2020)
6.2 Germany Insulin Sales and Growth Rate (2015-2020)
6.3 UK Insulin Sales and Growth Rate (2015-2020)
6.4 France Insulin Sales and Growth Rate (2015-2020)
6.5 Russia Insulin Sales and Growth Rate (2015-2020)
6.6 Italy Insulin Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Insulin Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Insulin Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Insulin Revenue and Market Share by Regions (2015-2020)
7.2 China Insulin Sales and Growth Rate (2015-2020)
7.3 Japan Insulin Sales and Growth Rate (2015-2020)
7.4 Korea Insulin Sales and Growth Rate (2015-2020)
7.5 India Insulin Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Insulin Sales and Growth Rate (2015-2020)
7.7 Australia Insulin Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Insulin Sales, Revenue and Market Share by Country
8.1.1 South America Insulin Sales and Market Share by Country (2015-2020)
8.1.2 South America Insulin Revenue and Market Share by Country (2015-2020)
8.2 Brazil Insulin Sales and Growth Rate (2015-2020)
8.3 Argentina Insulin Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Insulin Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Insulin Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Insulin Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Insulin Sales and Growth Rate (2015-2020)
9.3 Turkey Insulin Sales and Growth Rate (2015-2020)
9.4 Egypt Insulin Sales and Growth Rate (2015-2020)
9.5 South Africa Insulin Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Insulin Sales and Market Share by Type (2015-2020)
10.2 Global Insulin Revenue and Market Share by Type (2015-2020)
10.3 Global Insulin Price by Type (2015-2020)
11 Global Insulin Market Segment by Application
11.1 Global Insulin Sales Market Share by Application (2015-2020)
11.2 Global Insulin Revenue Market Share by Application (2015-2020)
11.3 Global Insulin Price by Application (2015-2020)
12 Market Forecast
12.1 Global Insulin Sales, Revenue and Growth Rate (2021-2025)
12.2 Insulin Market Forecast by Regions (2021-2025)
12.2.1 North America Insulin Market Forecast (2021-2025)
12.2.2 Europe Insulin Market Forecast (2021-2025)
12.2.3 Asia-Pacific Insulin Market Forecast (2021-2025)
12.2.4 South America Insulin Market Forecast (2021-2025)
12.2.5 Middle East & Africa Insulin Market Forecast (2021-2025)
12.3 Insulin Market Forecast by Type (2021-2025)
12.3.1 Global Insulin Sales Forecast by Type (2021-2025)
12.3.2 Global Insulin Market Share Forecast by Type (2021-2025)
12.4 Insulin Market Forecast by Application (2021-2025)
12.4.1 Global Insulin Sales Forecast by Application (2021-2025)
12.4.2 Global Insulin Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Insulin Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Insulin by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Insulin Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Insulin Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 9. Novo Nordisk Insulin Major Business
Table 10. Novo Nordisk Insulin Total Revenue (USD Million) (2018-2019)
Table 11. Novo Nordisk SWOT Analysis
Table 12. Novo Nordisk Insulin Product and Services
Table 13. Novo Nordisk Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Tonghua Dongbao Basic Information, Manufacturing Base and Competitors
Table 15. Tonghua Dongbao Insulin Major Business
Table 16. Tonghua Dongbao Insulin Total Revenue (USD Million) (2018-2019)
Table 17. Tonghua Dongbao SWOT Analysis
Table 18. Tonghua Dongbao Insulin Product and Services
Table 19. Tonghua Dongbao Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 21. Eli Lilly Insulin Major Business
Table 22. Eli Lilly Insulin Total Revenue (USD Million) (2018-2019)
Table 23. Eli Lilly SWOT Analysis
Table 24. Eli Lilly Insulin Product and Services
Table 25. Eli Lilly Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Jiangsu Wanbang Basic Information, Manufacturing Base and Competitors
Table 27. Jiangsu Wanbang Insulin Major Business
Table 28. Jiangsu Wanbang Insulin Total Revenue (USD Million) (2018-2019)
Table 29. Jiangsu Wanbang SWOT Analysis
Table 30. Jiangsu Wanbang Insulin Product and Services
Table 31. Jiangsu Wanbang Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
Table 33. Sanofi-Aventis Insulin Major Business
Table 34. Sanofi-Aventis Insulin Total Revenue (USD Million) (2018-2019)
Table 35. Sanofi-Aventis SWOT Analysis
Table 36. Sanofi-Aventis Insulin Product and Services
Table 37. Sanofi-Aventis Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. United Laboratory Basic Information, Manufacturing Base and Competitors
Table 39. United Laboratory Insulin Major Business
Table 40. United Laboratory Insulin Total Revenue (USD Million) (2018-2019)
Table 41. United Laboratory SWOT Analysis
Table 42. United Laboratory Insulin Product and Services
Table 43. United Laboratory Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Ganlee Basic Information, Manufacturing Base and Competitors
Table 45. Ganlee Insulin Major Business
Table 46. Ganlee Insulin Total Revenue (USD Million) (2018-2019)
Table 47. Ganlee SWOT Analysis
Table 48. Ganlee Insulin Product and Services
Table 49. Ganlee Insulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Global Insulin Sales by Manufacturer (2018-2019) (M Pcs)
Table 51. Global Insulin Revenue by Manufacturer (2018-2019) (USD Million)
Table 52. Global Insulin Sales by Regions (2015-2020) (M Pcs)
Table 53. Global Insulin Sales Market Share by Regions (2015-2020)
Table 54. Global Insulin Revenue by Regions (2015-2020) (USD Million)
Table 55. North America Insulin Sales by Countries (2015-2020) (M Pcs)
Table 56. North America Insulin Sales Market Share by Countries (2015-2020)
Table 57. North America Insulin Revenue by Countries (2015-2020) (USD Million)
Table 58. North America Insulin Revenue Market Share by Countries (2015-2020)
Table 59. Europe Insulin Sales by Countries (2015-2020) (M Pcs)
Table 60. Europe Insulin Sales Market Share by Countries (2015-2020)
Table 61. Europe Insulin Revenue by Countries (2015-2020) (USD Million)
Table 62. Asia-Pacific Insulin Sales by Regions (2015-2020) (M Pcs)
Table 63. Asia-Pacific Insulin Sales Market Share by Regions (2015-2020)
Table 64. Asia-Pacific Insulin Revenue by Regions (2015-2020) (USD Million)
Table 65. South America Insulin Sales by Countries (2015-2020) (M Pcs)
Table 66. South America Insulin Sales Market Share by Countries (2015-2020)
Table 67. South America Insulin Revenue by Countries (2015-2020) (USD Million)
Table 68. South America Insulin Revenue Market Share by Countries (2015-2020)
Table 69. Middle East & Africa Insulin Sales by Countries (2015-2020) (M Pcs)
Table 70. Middle East & Africa Insulin Sales Market Share by Countries (2015-2020)
Table 71. Middle East & Africa Insulin Revenue by Countries (2015-2020) (USD Million)
Table 72. Middle East & Africa Insulin Revenue Market Share by Countries (2015-2020)
Table 73. Global Insulin Sales by Type (2015-2020) (M Pcs)
Table 74. Global Insulin Sales Share by Type (2015-2020)
Table 75. Global Insulin Revenue by Type (2015-2020) (USD Million)
Table 76. Global Insulin Revenue Share by Type (2015-2020)
Table 77. Global Insulin Sales by Application (2015-2020) (M Pcs)
Table 78. Global Insulin Sales Share by Application (2015-2020)
Table 79. Global Insulin Sales Forecast by Regions (2021-2025) (M Pcs)
Table 80. Global Insulin Market Share Forecast by Regions (2021-2025)
Table 81. Global Insulin Sales Forecast by Type (2021-2025) (M Pcs)
Table 82. Global Insulin Market Share Forecast by Type (2021-2025)
Table 83. Global Insulin Sales Forecast by Application (2021-2025)
Table 84. Global Insulin Market Share Forecast by Application (2021-2025)
Table 85. Direct Channel Pros & Cons
Table 86. Indirect Channel Pros & Cons
Table 87. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Insulin Picture
Figure 2. Global Sales Market Share of Insulin by Type in 2019
Figure 3. Animal Insulin Picture
Figure 4. Regular Human Insulin Picture
Figure 5. Insulin Analogue Picture
Figure 6. Insulin Sales Market Share by Application in 2019
Figure 7. Short acting Picture
Figure 8. Intermediate acting Picture
Figure 9. Long acting Picture
Figure 10. Pre-mix Insulin Picture
Figure 11. Global Insulin Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Insulin Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Insulin Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Insulin Sales Market Share by Manufacturer in 2019
Figure 32. Global Insulin Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Insulin Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Insulin Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Insulin Sales and Growth Rate (2015-2020) (M Pcs)
Figure 37. Global Insulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Insulin Revenue Market Share by Regions (2015-2020)
Figure 39. Global Insulin Revenue Market Share by Regions in 2018
Figure 40. North America Insulin Sales and Growth Rate (2015-2020)
Figure 41. Europe Insulin Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Insulin Sales and Growth Rate (2015-2020)
Figure 43. South America Insulin Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Insulin Sales and Growth Rate (2015-2020)
Figure 45. North America Insulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Insulin Sales Market Share by Countries (2015-2020)
Figure 47. North America Insulin Sales Market Share by Countries in 2018
Figure 48. North America Insulin Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Insulin Revenue Market Share by Countries in 2018
Figure 50. United States Insulin Sales and Growth Rate (2015-2020) (M Pcs)
Figure 51. Canada Insulin Sales and Growth Rate (2015-2020) (M Pcs)
Figure 52. Mexico Insulin Sales and Growth Rate (2015-2020) (M Pcs)
Figure 53. Europe Insulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Insulin Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Insulin Revenue Market Share by Countries in 2019
Figure 56. Germany Insulin Sales and Growth Rate (2015-2020) (M Pcs)
Figure 57. UK Insulin Sales and Growth Rate (2015-2020) (M Pcs)
Figure 58. France Insulin Sales and Growth Rate (2015-2020) (M Pcs)
Figure 59. Russia Insulin Sales and Growth Rate (2015-2020) (M Pcs)
Figure 60. Italy Insulin Sales and Growth Rate (2015-2020) (M Pcs)
Figure 61. Asia-Pacific Insulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Insulin Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Insulin Revenue Market Share by Regions 2019
Figure 64. China Insulin Sales and Growth Rate (2015-2020) (M Pcs)
Figure 65. Japan Insulin Sales and Growth Rate (2015-2020) (M Pcs)
Figure 66. Korea Insulin Sales and Growth Rate (2015-2020) (M Pcs)
Figure 67. India Insulin Sales and Growth Rate (2015-2020) (M Pcs)
Figure 68. Southeast Asia Insulin Sales and Growth Rate (2015-2020) (M Pcs)
Figure 69. South America Insulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Insulin Sales Market Share by Countries in 2019
Figure 71. South America Insulin Revenue Market Share by Countries in 2019
Figure 72. Brazil Insulin Sales and Growth Rate (2015-2020) (M Pcs)
Figure 73. Argentina Insulin Sales and Growth Rate (2015-2020) (M Pcs)
Figure 74. Middle East and Africa Insulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Insulin Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Insulin Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Insulin Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Insulin Sales and Growth Rate (2015-2020) (M Pcs)
Figure 79. Egypt Insulin Sales and Growth Rate (2015-2020) (M Pcs)
Figure 80. Turkey Insulin Sales and Growth Rate (2015-2020) (M Pcs)
Figure 81. South Africa Insulin Sales and Growth Rate (2015-2020) (M Pcs)
Figure 82. Global Insulin Sales and Growth Rate (2021-2025) (M Pcs)
Figure 83. Global Insulin Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Insulin Market Forecast (2021-2025) (M Pcs)
Figure 85. Europe Sales Insulin Market Forecast (2021-2025) (M Pcs)
Figure 86. Asia-Pacific Sales Insulin Market Forecast (2021-2025) (M Pcs)
Figure 87. South America Sales Insulin Market Forecast (2021-2025) (M Pcs)
Figure 88. Middle East & Africa Sales Insulin Market Forecast (2021-2025) (M Pcs)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel